Todos os estudos
RecrutamentoFASE2INTERVENCIONISTA

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)

This research is looking at a new vaccine, called mRNA-1982, designed to protect people from Lyme disease. The main goals are to check if it's safe to use, how your body reacts to it (like if you get a sore arm), and how well it helps your body build up protection against Lyme disease. The study includes healthy adults between 18 and 70 years old. Some participants will receive the new vaccine, while others will get a placebo (a dummy injection with no active medicine). This helps researchers understand the vaccine's real effects. This is a Phase 2 trial, meaning it's a further step in testing after initial safety checks.

Em resumo

Status
Recrutamento
Fase
FASE2
Patrocinador
ModernaTX, Inc.
Meta de inscrição
350
Iniciar
29 Abr 2026
Conclusão estimada
09 Nov 2028

Sobre o que é este estudo?

You might have heard about Lyme disease, which is an illness you can get from a tick bite. It can cause problems like rashes, headaches, and tiredness, and sometimes more serious issues if not treated. Scientists are currently working on new ways to prevent it.

This particular study is focused on a new type of vaccine called mRNA-1982. This vaccine uses a special message, called mRNA, to teach your body to fight off the bacteria that cause Lyme disease. It's similar to how some of the recent COVID-19 vaccines work. The main idea is to see if this vaccine can safely prepare your body's immune system to recognise and fight off the Lyme disease bacteria before you ever get sick.

The researchers want to learn two main things: firstly, how safe the vaccine is and what side effects people might experience (like a sore arm or feeling a bit under the weather). Secondly, they want to find out how well the vaccine helps your body create protective substances, called antibodies, to guard against Lyme disease. By comparing results from people who get the vaccine with those who get a dummy injection (placebo), they can get a clearer picture of the vaccine's benefits.

Pontos principais

  • This study is testing a new mRNA vaccine (mRNA-1982) for Lyme disease.
  • It aims to check the vaccine's safety and how well it helps your body fight off Lyme disease.
  • Healthy adults aged 18-70 can apply to participate.
  • You might receive the vaccine or a dummy injection (placebo).
  • A participação envolve visitas regulares à clínica e exames de saúde.
  • Você pode se retirar do estudo a qualquer momento.

Quem pode ser elegível?

To join this study, you need to be a healthy adult between 18 and 70 years old. A doctor will check your overall health to make sure you are suitable. If you could become pregnant, you'll need to use reliable birth control methods during the study.

However, there are some reasons why you might not be able to take part. For example, if you've ever had a very serious allergic reaction to any mRNA vaccine or its ingredients, this study wouldn't be right for you. Also, if you currently have Lyme disease, or have had it treated in the last three months, or have a long-term illness linked to Lyme disease, you wouldn't be able to join.

If you've already had a Lyme disease vaccine before, or if you had a tick bite very recently (within four weeks before the study starts), you also wouldn't be eligible. The study team will go through all these details with you carefully to see if you can take part.

Este estudo pode ser adequado para você?

Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.

  1. Are you between 18 and 70 years old?
  2. Do you feel generally healthy?
  3. Have you *never* had a serious allergic reaction to an mRNA vaccine?
  4. Have you *not* had Lyme disease in the last 3 months?
  5. Have you *not* had a tick bite in the last 4 weeks?
  6. Have you *never* had a Lyme disease vaccine before?
Responda a todas as perguntas para ver o seu resultado.

O que envolve a participação?

Taking part in this study would involve several visits to a clinic over a period of time. You would receive either the new mRNA-1982 vaccine or a placebo (a dummy injection) – you wouldn't know which one you received. During your visits, doctors and nurses would check your health, ask about any side effects, and take blood samples to see how your body is responding to the vaccine or placebo. You would be closely monitored throughout the study to track your health and any reactions. The total duration of your involvement in the study would be explained to you in detail by the study team.

Riscos e benefícios potenciais

The potential benefit of taking part is contributing to scientific knowledge that could lead to a new way to prevent Lyme disease. If you receive the vaccine, your body might also develop protection against Lyme disease, though this is not guaranteed as it's still being tested. Potential risks include common vaccine side effects like a sore arm, fever, or headache, or less common allergic reactions. As with any medical study, there's always a small chance of unforeseen risks. You have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (8)

  • Colchester Research Group
    Código postal verificado
    Truro, Canada· Recrutamento
  • Bluewater Clinical Research Group Inc.
    Código postal verificado
    Sarnia, Canada· Recrutamento
  • Stouffville Medical Research Institute Inc.
    Código postal verificado
    Stouffville, Canada· Recrutamento
  • Dr. Anil K. Gupta Medicine Professional Corporation Inc.
    Código postal verificado
    Toronto, Canadá· Recrutamento
  • Diex Recherche Inc. - Division Joliette
    Código postal verificado
    Joliette, Canada· Recrutamento
  • Diex Recherche Inc. - Division Sherbrooke
    Código postal verificado
    Sherbrooke, Canada· Recrutamento
  • Diex Recherche Inc. - Division Victoriaville
    Código postal verificado
    Victoriaville, Canada· Recrutamento
  • Diex Recherche Inc. - Division Quebec
    Código postal verificado
    Québec, Canada· Recrutamento

Perguntas frequentes

What is an mRNA vaccine?

An mRNA vaccine teaches your body's cells to make a small, harmless piece of a germ. This teaches your immune system to recognise and fight the actual germ if you get infected in the future.

What is a Phase 2 trial?

A Phase 2 trial is when a new treatment or vaccine is given to a larger group of people to see if it's safe and effective, and to find the right dose. It's a key step after initial safety checks.

Will I get Lyme disease from the vaccine?

No, you cannot get Lyme disease from this vaccine. It doesn't contain the actual bacteria that cause the disease, just the genetic instructions to help your body learn to fight it.

O que é um placebo?

A placebo is a 'dummy' treatment that looks just like the real vaccine but contains no active medicine. It helps researchers compare results accurately.

Quanto tempo estarei no estudo?

The exact duration would be explained by the study team, but clinical trials often involve several visits over many months to monitor your health.

Como saber mais

Moderna WeCare Team

Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.

Interessado em participar?

Registre seu interesse

Compartilhe seus detalhes e a equipe de pesquisa para "A Study to Evaluate the Safety, Reactogenicity, and Immunoge…" entrará em contato com você se você for elegível. Sempre fale com seu médico antes de concordar em participar.

Discussão

Discussão da comunidade

Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.